LivingGLP1
Study S002660

Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice

Registration

Registration
NCT07588750
Acronym
SIBUTAMATE
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
278
Start
2026-06-01
Primary completion
2026-08-01
Lead sponsor
Falquetomed
Conditions
Obesity & Overweight
Interventions
DRUG:Sibutramine + Topiramate
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
OTHER:SIBTOP-2026

Registered primary outcomes

  • Percent Change in Body Weight [Baseline to 12 months]
  • Change in Body Mass Index (BMI) [Baseline to 12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.